Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Arterial Embolization of Hepatocellular Carcinoma With a Doxorubicin Eluting Bead

NCT01259024 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01259024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01259024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Arterial Embolization of Hepatocellular Carcinoma With a Doxorubicin Eluting Bead
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2011
Completion date
April 30, 2012
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma